{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:54:53Z","timestamp":1794488093453,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019921","name":"National Scleroderma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001844","name":"Scleroderma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007475","name":"Canadian Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.lana.2024.100790","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T01:23:32Z","timestamp":1718241812000},"page":"100790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Epidemiology of systemic sclerosis in Quebec, Canada: a population-based study"],"prefix":"10.1016","volume":"35","author":[{"given":"Anastasiya","family":"Muntyanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-1909","authenticated-orcid":false,"given":"Katherine","family":"Aw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Kaouache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rahme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3580-6074","authenticated-orcid":false,"given":"Mohamed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ghazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-7787","authenticated-orcid":false,"given":"Elena","family":"Netchiporouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lana.2024.100790_bib1","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lana.2024.100790_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a delphi consensus study from EULAR scleroderma trials and research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lana.2024.100790_bib3","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","article-title":"Progression of patients with Raynaud\u2019s phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for very early diagnosis of systemic sclerosis (VEDOSS)","volume":"3","author":"Bellando-Randone","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.lana.2024.100790_bib4","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/1756-185X.13716","article-title":"Prevalence and incidence of systemic sclerosis: a systematic review and meta-analysis","volume":"22","author":"Zhong","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.lana.2024.100790_bib5","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","article-title":"Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis","volume":"60","author":"Bairkdar","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.lana.2024.100790_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lana.2024.100790_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.lana.2024.100790_bib8","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3899\/jrheum.101149","article-title":"The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases","volume":"38","author":"Bernatsky","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.lana.2024.100790_bib9","series-title":"Negative binomial regression","author":"Hilbe","year":"2011"},{"key":"10.1016\/j.lana.2024.100790_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.sste.2021.100420","article-title":"Evaluating the informativeness of the Besag-York-Molli\u00e9 CAR model","volume":"37","author":"Quick","year":"2021","journal-title":"Spat Spatiotemporal Epidemiol"},{"key":"10.1016\/j.lana.2024.100790_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41927-018-0043-6","article-title":"Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study","volume":"2","author":"Butt","year":"2018","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.lana.2024.100790_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.lana.2024.100790_bib13","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/art.42330","article-title":"Increasing prevalence of antinuclear antibodies in the United States","volume":"74","author":"Dinse","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"10391","key":"10.1016\/j.lana.2024.100790_bib14","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lana.2024.100790_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.lana.2024.100790_bib16","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lana.2024.100790_bib17","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s10067-018-4182-3","article-title":"The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink","volume":"37","author":"Royle","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lana.2024.100790_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","article-title":"Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature","volume":"92","author":"Gelber","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.lana.2024.100790_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008980","article-title":"Clinical and serological features of systemic sclerosis in a multicenter African American cohort: analysis of the genome research in African American scleroderma patients clinical database","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.lana.2024.100790_bib20","first-page":"2143","article-title":"Incidence of systemic connective tissue diseases in children: a nationwide prospective study in Finland","volume":"21","author":"Pelkonen","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.lana.2024.100790_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00296-020-04720-3","article-title":"Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data","volume":"41","author":"Ciaffi","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.lana.2024.100790_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","article-title":"Determinants of morbidity and mortality of systemic sclerosis in Canada","volume":"39","author":"Al-Dhaher","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.lana.2024.100790_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lana.2024.100790_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/14799731221125559","article-title":"Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: a nationwide retrospective cohort study","volume":"19","author":"Knarborg","year":"2022","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.lana.2024.100790_bib25","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/acr.24411","article-title":"Trends in systemic sclerosis mortality over forty-eight years, 1968-2015: a US population-based study","volume":"73","author":"Yen","year":"2021","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.lana.2024.100790_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lana.2024.100790_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lana.2024.100790_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/1756-185X.13111","article-title":"Mortality in the waikato hospital systemic sclerosis cohort","volume":"21","author":"Ooi","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.lana.2024.100790_bib29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/rheumatology\/37.7.750","article-title":"Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)","volume":"37","author":"Jacobsen","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.lana.2024.100790_bib30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2021.12.055","article-title":"Geographical distribution of systemic sclerosis in Canada: an ecologic study based on the Canadian Scleroderma Research Group","volume":"87","author":"Muntyanu","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.lana.2024.100790_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2021.03.055","article-title":"Geographic distribution and environmental triggers of systemic sclerosis cases from 2 large academic tertiary centers in Massachusetts","volume":"86","author":"Kassamali","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.lana.2024.100790_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaad.2023.04.062","article-title":"Organic solvent exposure and systemic sclerosis: a retrospective cohort study based on the Canadian Scleroderma Research Group registry","volume":"90","author":"Muntyanu","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X24001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X24001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T15:38:52Z","timestamp":1721057932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X24001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":32,"alternative-id":["S2667193X24001170"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2024.100790","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of systemic sclerosis in Quebec, Canada: a population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2024.100790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100790"}}